Jay D. Kranzler, CEO at CYPRESS BIOSCIENCE INC (CYPB), sold 24,000 shares at $13.51 ($324K) on 2007-10-22, disclosed to the SEC on 2007-10-24.
Scheduled sale ($324k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.30 | 300 | $4K | 1.2% |
| 2 | $13.31 | 300 | $4K | 1.2% |
| 3 | $13.32 | 900 | $12K | 3.7% |
| 4 | $13.34 | 300 | $4K | 1.2% |
| 5 | $13.35 | 300 | $4K | 1.2% |
| 6 | $13.37 | 355 |
| $5K |
| 1.5% |
| 7 | $13.38 | 100 | $1K | 0.4% |
| 8 | $13.39 | 145 | $2K | 0.6% |
| 9 | $13.40 | 300 | $4K | 1.2% |
| 10 | $13.41 | 100 | $1K | 0.4% |
| 11 | $13.42 | 500 | $7K | 2.1% |
| 12 | $13.43 | 300 | $4K | 1.2% |
| 13 | $13.44 | 300 | $4K | 1.2% |
| 14 | $13.45 | 1,366 | $18K | 5.7% |
| 15 | $13.46 | 1,034 | $14K | 4.3% |
| 16 | $13.47 | 1,483 | $20K | 6.2% |
| 17 | $13.48 | 2,400 | $32K | 10.0% |
| 18 | $13.49 | 2,317 | $31K | 9.7% |
| 19 | $13.50 | 1,100 | $15K | 4.6% |
| 20 | $13.51 | 500 | $7K | 2.1% |
| 21 | $13.52 | 700 | $9K | 2.9% |
| 22 | $13.53 | 2,000 | $27K | 8.4% |
| 23 | $13.54 | 300 | $4K | 1.3% |
| 24 | $13.55 | 100 | $1K | 0.4% |
| 25 | $13.56 | 1,000 | $14K | 4.2% |
| 26 | $13.57 | 400 | $5K | 1.7% |
| 27 | $13.58 | 700 | $10K | 2.9% |
| 28 | $13.59 | 1,400 | $19K | 5.9% |
| 29 | $13.60 | 1,600 | $22K | 6.7% |
| 30 | $13.61 | 1,400 | $19K | 5.9% |
| Total | $13.50 avg | 24,000 | $324K | 100% |
| Filing → |
| CYPB | SELL | 2010-12-29 | $162K | — | Filing → |
| CYPB | SELL | 2010-12-29 | $983K | — | Filing → |
| CYPB | SELL | 2009-08-04 | $652K | — | Filing → |